|Articles|July 21, 2016
Medidata Collaborates with MSK Cancer Center
Medidata announces a collaboration with New York’s Memorial Sloan Kettering Cancer Center on a pilot study to expand the use of mHealth technology in oncology treatment.
Advertisement
Medidata announces a collaboration with New York’s Memorial Sloan Kettering Cancer Center on a pilot study to expand the use of mHealth technology in treatment for multiple myeloma. The companies will assess the viability of wearable sensors and mobile technology to evaluate patient quality of life during treatment.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What It Actually Means to Embed the Patient Voice in Trial Design
2
Recruitment in the Age of AI: Q&A with John Worden, Javara
3
Beyond Compliance: NetraMark's Joseph Geraci, PhD, on Making AI-Driven Patient Subgroups Explainable
4
ACT Brief: Explainable AI for Patient Subgroups, Participant Understanding and Engagement, and FDA Leadership Stabilization
5